Congratulations to our 2020 Awardees!
Infection Control Advice for Dental Professions Decision-Makers in the COVID-19 Pandemic
(April 3rd, 2020). See the latest work from Drs PJ Allison, S. Madathil, M. Morris & R. Freitas de Souza which is supported by the RSBO:
Teledentistry during and post COVID-19 (Kengne Talla, P., Levin L., Glogauer M., Cable, C. , Allison, PJ. ):
Protocoles de prévention des infections au COVID-19 et guide pratique pour les professionnels en santé dentaire et les décideurs (avril 2020): Voyez les travaux des Drs PJ Allison, S. Madathil, M. Morris et R. Freitas de Souza qui ont obtenu un soutien financier du RSBO.
Télédentisterie en temps de pandémie (Kengne Talla, P., Levin L., Glogauer M., Cable, C. , Allison, PJ. ):
Cliquez ici :
We are launching again our annual video competition for students and trainees!
Are you up for the challenge? Several prices up to 500$ will be given!
To help you in the process, we are organizing a workshop on ho to make your own video, on May 6th at noon
At its meeting of November 22, the FRQS Board of Directors has endorsed the candidatures of Dr. Christophe Bedos and Dr. Faleh Tamimi as co-directors of the Québec Network for Oral and Bone Health Research.
Christophe Bedos is a dentist with a PhD in public health. He is an Associate Professor with the Faculty of Dentistry of McGill University and Adjunct Professor with the School of public health of Université de Montréal. His research focuses mainly on access to care for the underprivileged and the development of person-centred dentistry.
Dr. Tamimi is a dentist who holds two clinical certificates, in Geriatric Dentistry, and in Implant-Prosthodontics, respectively, as well as a Ph.D. in Biomaterials. He is Also a Canada Research Chair in Translational Craniofacial Research.
Congratulations and best wishes for success !
Le Professeur Dieter Reinhardt a participé à une collaboration unique entre l’Hôpital Schriners pour enfant – Canada, le CHU Sainte Justine et l’Université McGill, permettant à des chercheurs d’identifier des mutations génétiques impliquées dans une maladie rare qui cause la scoliose et des malformations osseuses. Les découvertes, publiées dans le American Journal of Human Genetics, sont suceptibles d’aider les médécins à diagnostiquer cette maladie génétique et pourraient amener à des pistes thérapeuthiques.
LAUNCHING OF THE 2018-2019 COMPETITION
Aim of this program
a) to enable researchers from different sites, fields and sectors, to establish teams and to unite their expertise around various research topics
b) to support innovative approaches that could lead to grants from major funding agencies in health research
c) to generate knowledge that could ultimately have major impacts on clinical outcomes, applied research and public health.
Launch of the program: 20 December 2017
Application deadline: 15 April 2018
Notice of decision: 15 June 2018
• The principal investigator must be a regular RSBO member.
• The application for funding must include a minimum of 3 RSBO researchers from at least 2 different universities.
• A member may submit only one application for this competition, as principal investigator (or co-principal investigator).
• A researcher who received a grant in the 2015-2016 competition of this program as principal investigator (or co-principal investigator) cannot submit an application as principal investigator (or co-principal investigator) in the present competition.
Maximum amount per funded project:
• Theme A: $25,000 per year
• Themes B and C: $50,000 per year
Maximal duration of the grant: 2 years. The second year of funding is subject to the submission of a progress report deemed satisfactory by the RSBO Executive Committee.
The total budget available for this competition is $125,000.
Conditions of Funding
Successful applicants funded through this program and any other persons working on the project must comply fully with the Fonds de recherche du Québec rules as stated in Les Règles générales communes which govern, among other things, eligible expenses.
During this transition year, the Executive Committee has chosen to renew two themes that were the subject of a request for applications two years ago (Theme A and B). Researchers who work on different research theme can nonetheless apply an application as long as their research topic is relevant to the RSBO mandate (Theme C “free”).
• Theme A: Accessibility to and promotion of oral and bone health care for vulnerable clienteles: The vulnerable clienteles include (non-exhaustive list) those with low incomes; people without dental insurance; elderly people living in institutions; aboriginal peoples; refugees and immigrants; those with disabilities; and people living in rural and remote regions.
• Theme B: Genetics/Genomics of dental, oral, craniofacial and musculoskeletal diseases. The goal is to better understand the genetics / genomics of oral, craniofacial and musculoskeletal diseases that have well-documented heritability. The ultimate goal is to develop effective diagnostic, therapeutic and preventive approaches.
• Theme C (free theme): Any theme that fits into the mandate of the RSBO.
To apply, please complete the application form.
Send the complete application form, signed by all principal investigators, to firstname.lastname@example.org by 5:00 pm on April 15, 2018.
• Scientific excellence of the proposal;
• Quality of the team (Level of networking and partnerships; Researchers’ CV);
• Quality of the project (Pertinence and innovation/originality; Anticipated benefits; Leverage effect; Budget and timetable)
See the Evaluation Grid
Funded researchers in the context of this program must:
• recognize the support of RSBO in all communications and publications resulting from the project
• produce a mini-video (2 or 3 minutes maximum) at the end of the project in which the team will briefly describe the project in non-technical terms. Additional funding and support will be available for the production of this video.
Professor Dieter Reinhardt was part of a unique collaboration among Shriners Hospital for Children – Canada, CHU Sainte-Justine and McGill University that has enabled researchers to identify genetic mutations involved in a rare disease that causes scoliosis and bone malformations. The findings, published in The American Journal of Human Genetics, are likely to help doctors recognize the genetic disease, and could someday lead to therapies for the condition.